TreatHF vs AngioAID 3D
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
TreatHF
This clinical decision support tool offers personalized heart failure therapy recommendations for healthcare professionals. It guides clinicians on medication initiation, titration, and optimization based on patient indications, referencing the latest guidelines.
- Individualized therapy suggestions
- Guidance on medication use
- Patient indication entry
- Next steps for medical therapy
- Medication initiation and titration
- Optimization of medication strategy
Read full descriptionHide full description
TreatHF is a clinical decision support app that provides clinicians individualized therapy suggestions for their symptomatic heart failure patients and provides guidance on the use of each therapy. • Enter patient indications • Review individualized next steps for medical therapy • Email or print a summary of the next steps • Reference detailed information for - Initiation, titration, and monitoring of each medication - Guidance for optimizing your overall medication strategy. Content in this app is derived from the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure, the 2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction, and the 2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction. The information and recommendations in this clinical decision support app are not meant to represent the only or best course of care nor replace clinical judgment. Therapeutic options should be determined after discussion between the patient and their care provider.
AngioAID 3D
An interactive 3D simulation for learning diagnostic angiography of coronary arteries. Practice advancing catheters, manipulating views, and injecting dye in a realistic environment. Includes review modes with key anatomical and procedural information.
- 3D live simulation of coronary angiography
- Interactive guidewire and catheter manipulation
- Hemodynamic monitoring
- C-Arm angle adjustment
- Dye injection and cine comparison
- Review Mode with anatomical insights
- Tutorial video
Read full descriptionHide full description
AngioAID 3D is educational tool designed to teach key concepts of diagnostic angiography of coronary arteries. Developed at the Mount Sinai Hospital in New York City, New York State's highest volume cardiac cath lab, we aim to provide an interactive learning experience on this important topic. Within a 3D live simulation, you begin by advancing a diagnostic guidewire into the aortic root. Then, advance one of many diagnostic catheter options to either the right of left coronary ostium. Through pushing and pulling, as well as rotation of the catheter, try to achieve a truly co-axial engagement of the coronary ostium with the catheter. Meanwhile monitor the hemodynamic tab which simulated damping from over-engagement or roofing of the catheter tip. Line up the view with the target view, zoom to fill the screen with he coronaries, and rotate the C-Arm LAO/RAO and Cranial/Caudal until you're where you think you need to be. Finally, inject dye and take a cine to compare with the one we actually did in the cath lab for this set of coronaries. In addition to the diagnostic simulation, "Review Mode" allows you to play with angles and panning while always being able to see the vessels with no dye injection needed. Also a collection of key topics have been included within the review mode such as key angiographic angles depending on what you're aiming to see clearly, vessel segmentation conventions, and more coronary anatomy and angiography pearls. We highly recommend you view the tutorial video that is available when you first open the application or from the settings page to understand all of the available functions. The first launch has a normal set of coronary arteries but please stay tuned while we create more sets of coronaries such as anomalous coronaries and bypass grafts.
Screenshots
Verdict
The clearest difference is rating: TreatHF at 5.0 against AngioAID 3D's 4.0. TreatHF also leads on ads (none vs shown) and update cadence (every 7 months vs every 28 months). On price, in-app purchases and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
TreatHF holds the better App Store score, 5.0 against 4.0. That said, the two scores are not equally well evidenced: TreatHF has 5 ratings behind it against 1, so its average is the more settled of the two.
TreatHF ships an update every 7 months, AngioAID 3D every 28 months. The most recent releases landed on November 20, 2026 and November 18, 2026 respectively.
| Parameter | TreatHF | AngioAID 3D |
|---|---|---|
| Price | Free | Free |
| Rating | 5.0 (5 ratings) — better | 4.0 (1 ratings) |
| Number of ratings | 5 — better | 1 |
| Update frequency | Every 7 months — better | Every 28 months |
| Ads | No — better | Yes |
| In-app purchases | No | No |
| Monetization | Free — better | Ad-supported |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 13.0 — better | 15.0 |
| Further details — not scored | ||
| Size | 13 MB | 92 MB |
| Age rating | 17+ | 17+ |
| Developer | American College of Cardiology | Cardiology Apps LLC |
Customer experience
TreatHF
AngioAID 3D
In-app purchases
TreatHF
No in-app purchases
AngioAID 3D
No in-app purchases









